Fortitude Family Office, LLC
Family OfficePosition in LLY — ELI LILLY & Co
CIK 1950506
SCOTTSDALE, AZ
Position in LLY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$3,653,464
+$899,673 QoQ
Shares Held
3,046
+1.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
3.71%
of 13F equity value
Holder Rank
#1,962
of 4,605 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$1,679,202
PutShares
1,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fortitude Family Office, LLC holds $6,252,480 across 11 Drug Manufacturers - General names. LLY ranks #1 (58.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
3,046 | $3,653,464 | |
| 2 | ABBV |
AbbVie Inc.
|
4,225 | $1,063,179 | |
| 3 | JNJ |
Johnson & Johnson
|
1,844 | $468,320 | |
| 4 | AMGN |
Amgen Inc
|
1,172 | $424,404 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,950 | $379,075 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
690 | $87,174 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,205 | $69,432 | |
| 8 | BIIB |
Biogen Inc.
|
315 | $68,058 |
All Filings in LLY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,653,464 | 3,046 | Shares | Sole | 2026-07-20 | |
| 2026-06-30 | $1,679,202 | 1,400 | Put | Sole | 2026-07-20 | |
| 2026-03-31 | $1,287,678 | 1,400 | Put | Sole | 2026-04-16 | |
| 2026-03-31 | $2,753,791 | 2,994 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $1,504,552 | 1,400 | Put | Sole | 2026-01-15 | |
| 2025-12-31 | $3,342,255 | 3,110 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,068,200 | 1,400 | Put | Sole | 2025-10-17 | |
| 2025-09-30 | $2,359,959 | 3,093 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1,091,342 | 1,400 | Put | Sole | 2025-07-15 | |
| 2025-06-30 | $2,418,102 | 3,102 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $1,156,274 | 1,400 | Put | Sole | 2025-04-16 | |
| 2025-03-31 | $2,294,377 | 2,778 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $2,542,968 | 3,294 | Shares | Sole | 2025-01-10 | |
| 2024-12-31 | $308,800 | 400 | Put | Sole | 2025-01-10 | |
| 2024-09-30 | $354,376 | 400 | Put | Sole | 2024-10-25 | |
| 2024-09-30 | $2,110,309 | 2,382 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $362,152 | 400 | Put | Sole | 2024-07-10 | |
| 2024-06-30 | $677,224 | 748 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $521,233 | 670 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $390,556 | 670 | Shares | Sole | 2024-01-12 | |
| No filing history on record for this holder in this stock. | ||||||